Skip to main content
Zafiris Daskalakis, MD, Psychiatry, San Diego, CA

ZafirisDaskalakisMD

Psychiatry San Diego, CA

Professor and Chair, Department of Psychiatry | Dr. Igor and JoAnn Grant Chair in Psychiatry | School of Medicine | UC San Diego Health Sciences

Dr. Daskalakis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Daskalakis' full profile

Already have an account?

  • Office

    200 W Arbor Dr
    San Diego, CA 92103
    Phone+1 800-926-8273
    Fax+1 888-539-8781

Summary

  • In 2020 I was appointed Chair of the Department of Psychiatry at UC San Diego. I was formerly the Temerty Chair and Chief of the General Adult Psychiatry at CAMH. My research focusses on neurophysiological and treatment studies using transcranial magnetic brain stimulation (rTMS) and magnetic seizure therapy (MST). I holds or have held numerous federal operating grants and awards. I have over 400 peer-reviewed publications, am editorial board member for Biological Psychiatry, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging and an Associate Editor for Clinical Neurophysiology. I am also a member of the Brain and Behavior Research Foundation (formerly NARSAD) Scientific Council.

Education & Training

  • Queen's University at Kingston
    Queen's University at KingstonClass of 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2021 - 2027

Publications & Presentations

PubMed

Press Mentions

  • UCSD Health Offers Procedure for Depression That’s ‘Going to Revolutionize How We Treat Mental Health’
    UCSD Health Offers Procedure for Depression That’s ‘Going to Revolutionize How We Treat Mental Health’January 23rd, 2022
  • BrainsWay Announces Prominent Addition to Scientific Advisory Board
    BrainsWay Announces Prominent Addition to Scientific Advisory BoardOctober 12th, 2021
  • Meta-Analysis: High Placebo Response in Treatment-Resistant Depression RCTs
    Meta-Analysis: High Placebo Response in Treatment-Resistant Depression RCTsSeptember 27th, 2021
  • Join now to see all